Recombinant GFRA3 (Nadecnemab Biosimilar) antibody

Catalog No. ABIN7666260

The Human Monoclonal anti-GFRA3 (Nadecnemab Biosimilar) antibody has been validated for . It is suitable to detect GFRA3 (Nadecnemab Biosimilar) in samples from Human.

Quick Overview for Recombinant GFRA3 (Nadecnemab Biosimilar) antibody (ABIN7666260)

Target: GFRA3 (Nadecnemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This GFRA3 (Nadecnemab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-GFRA3 (Nadecnemab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: GFRA3 antibody (Nadecnemab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for GFRA3 (Nadecnemab Biosimilar)

Target: GFRA3 (Nadecnemab Biosimilar)

Alternative Name: Nadecnemab biosimilar

Target Type: Biosimilar

Background: Nadecnemab | GFRA3

Gene ID: 2676

UniProt: O60609